Chronic Kidney Disease
Ace the Case: A 22-Year-Old Man With Hematuria
There is no commercial support for this activity.
IV iron therapy may not improve exercise ability in patients with CKD
Intravenous iron therapy did not improve exercise capacity in nonanemic patients with iron deficiency who have chronic kidney disease, according to recently published data.
Treating high BP can reduce the risks of ESKD, but measuring it correctly is key
“The most important skill you will learn in your medical career is to measure blood pressure. Do it correctly and you will help more patients to better health than with any other skill you learn. Do it wrong and you will harm more patients than with any other medical errors you make over your career.” — Clarence E. Grim, MD
Healio celebrates National Nurses Month
With May serving as National Nurses Month, Healio has collected the top stories in nephrology that discuss the challenges faced by nurses who treat patients with kidney disease.
Empagliflozin HF benefits extend across spectrum of kidney disease
Kidney disease does not influence the benefits of the SGLT2 inhibitor empagliflozin on major HF events, even in patients at high renal risk, according to a new analysis of the EMPEROR-Pooled study.
High post-dexamethasone cortisol levels linked to lower eGFR independent of CV factors
SEATTLE — Higher post-dexamethasone cortisol was associated with lower estimated glomerular filtration rate independent of cardiovascular risk factors, researchers reported at the AACE Annual Scientific and Clinical Conference.
Gene testing more beneficial than clinical review in identifying Townes-Brocks Syndrome
AUSTIN, Texas — A broad kidney gene panel will frequently help diagnosis renal syndromes more effectively than classical clinical review alone, researchers reported here.
FDA grants fast-track designation to potential CD19-CAR T cell therapy for lupus
The FDA has granted fast-track designation to CABA-201, a CD19-CAR T cell investigational therapy, for the treatment of systemic lupus erythematous and lupus nephritis, according to a press release from the manufacturer.
Healio celebrates Mental Health Awareness Month
With May serving as Mental Health Awareness Month, Healio has collected the top stories in nephrology that discuss mental health, burnout and the mental burden kidney disease can have on patients and providers.
Akebia receives European approval for anemia drug
Akebia Therapeutics Inc. has received approval from the European Commission to market its oral hypoxia-inducible factor prolyl hydroxylase inhibitor Vafseo in Europe, according to a press release.